N. Slim

995 total citations
30 papers, 400 citations indexed

About

N. Slim is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, N. Slim has authored 30 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 13 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in N. Slim's work include Colorectal Cancer Surgical Treatments (12 papers), Radiomics and Machine Learning in Medical Imaging (10 papers) and Advanced Radiotherapy Techniques (10 papers). N. Slim is often cited by papers focused on Colorectal Cancer Surgical Treatments (12 papers), Radiomics and Machine Learning in Medical Imaging (10 papers) and Advanced Radiotherapy Techniques (10 papers). N. Slim collaborates with scholars based in Italy, France and Canada. N. Slim's co-authors include Paolo Passoni, R. Calandrino, Michele Reni, N. Di Muzio, Giovanni Mauro Cattaneo, C. Fiorino, S. Broggi, Gianpaolo Balzano, Roberto Nicoletti and Stefano Cereda and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

N. Slim

26 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N. Slim Italy	12	307	160	145	109	80	30	400
Lois A. Daamen Netherlands	10	251 0.8×	57 0.4×	127 0.9×	36 0.3×	118 1.5×	47	348
Jun Dang China	15	220 0.7×	141 0.9×	344 2.4×	94 0.9×	73 0.9×	43	497
R. Matute Spain	7	189 0.6×	123 0.8×	104 0.7×	71 0.7×	144 1.8×	16	301
M. Gómez-Espí Spain	12	328 1.1×	75 0.5×	127 0.9×	63 0.6×	245 3.1×	19	398
Ning-Ning Lu China	10	182 0.6×	58 0.4×	83 0.6×	61 0.6×	61 0.8×	54	350
Sameh Hashem Jordan	10	124 0.4×	59 0.4×	98 0.7×	70 0.6×	109 1.4×	16	273
K.S. Keene United States	10	87 0.3×	90 0.6×	85 0.6×	105 1.0×	58 0.7×	29	323
J. Shaffer United States	8	111 0.4×	83 0.5×	95 0.7×	66 0.6×	49 0.6×	18	329
Takuhito Tada Japan	13	197 0.6×	126 0.8×	335 2.3×	197 1.8×	72 0.9×	37	507
Stefan Münch Germany	12	100 0.3×	79 0.5×	221 1.5×	81 0.7×	212 2.6×	40	368

Countries citing papers authored by N. Slim

Since Specialization

Citations

This map shows the geographic impact of N. Slim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Slim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Slim more than expected).

Fields of papers citing papers by N. Slim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Slim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Slim. The network helps show where N. Slim may publish in the future.

Co-authorship network of co-authors of N. Slim

This figure shows the co-authorship network connecting the top 25 collaborators of N. Slim. A scholar is included among the top collaborators of N. Slim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Slim. N. Slim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burgio, Valentina, Monica Ronzoni, Paolo Passoni, et al.. (2024). Induction chemotherapy plus concomitant oxaliplatin-based chemoradiotherapy for locally advanced rectal cancer: A real world experience at San Raffaele Hospital.. Journal of Clinical Oncology. 42(3_suppl). 144–144. 1 indexed citations

Passoni, Paolo, Michele Reni, S. Broggi, et al.. (2024). Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma. Clinical and Translational Radiation Oncology. 47. 100778–100778.

Broggi, S., Paolo Passoni, Paolo Tiberio, et al.. (2023). Stomach and duodenum dose–volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in combination with chemotherapy. Frontiers in Oncology. 12. 983984–983984. 2 indexed citations

Nardi, Paola De, Massimiliano Mistrangelo, Paolo Passoni, et al.. (2020). Tailoring the radiotherapy approach in patients with anal squamous cell carcinoma based on inguinal sentinel lymph node biopsy. Journal of Surgical Oncology. 123(1). 315–321. 4 indexed citations

Incerti, Elena, Emilia Giovanna Vanoli, S. Broggi, et al.. (2019). Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients. Nuclear Medicine Communications. 40(10). 1072–1080. 1 indexed citations

Fiorino, C., Paolo Passoni, Anna Palmisano, et al.. (2019). Accurate outcome prediction after neo-adjuvant radio-chemotherapy for rectal cancer based on a TCP-based early regression index. Clinical and Translational Radiation Oncology. 19. 12–16. 14 indexed citations

Palmisano, Anna, Antonio Esposito, Paola M. V. Rancoita, et al.. (2018). Could perfusion heterogeneity at dynamic contrast-enhanced MRI be used to predict rectal cancer sensitivity to chemoradiotherapy?. Clinical Radiology. 73(10). 911.e1–911.e7. 14 indexed citations

Palmisano, Anna, Antonio Esposito, Alessandro Ambrosi, et al.. (2018). Could early tumour volume changes assessed on morphological MRI predict the response to chemoradiation therapy in locally-advanced rectal cancer?. Clinical Radiology. 73(6). 555–563. 17 indexed citations

Fiorino, C., Paolo Passoni, Anna Palmisano, et al.. (2018). A TCP-based early regression index predicts the pathological response in neo-adjuvant radio-chemotherapy of rectal cancer. Radiotherapy and Oncology. 128(3). 564–568. 26 indexed citations

10.

Slim, N., Paolo Parise, Elena Mazza, et al.. (2018). EP-1449: Neoadjuvant chemoradiotherapy IG-IMRT PET based in esophageal or esophageal gastric junction cancer. Radiotherapy and Oncology. 127. S787–S787.

11.

Reni, Michele, Silvia Zanon, Gianpaolo Balzano, et al.. (2017). Selecting patients for resection after primary chemotherapy for non-metastatic pancreatic adenocarcinoma. Annals of Oncology. 28(11). 2786–2792. 73 indexed citations

12.

Scalco, Elisa, C. Fiorino, S. Broggi, et al.. (2015). Assessment and clinical validation of margins for adaptive simultaneous integrated boost in neo-adjuvant radiochemotherapy for rectal cancer. Physica Medica. 31(2). 167–172. 20 indexed citations

13.

Macchia, Gabriella, A. Sainato, Renato Talamini, et al.. (2015). Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey. Oncology Reports. 34(1). 382–390. 2 indexed citations

14.

Passoni, Paolo, C. Fiorino, N. Slim, et al.. (2013). Feasibility of an Adaptive Strategy in Preoperative Radiochemotherapy for Rectal Cancer With Image-Guided Tomotherapy: Boosting the Dose to the Shrinking Tumor. International Journal of Radiation Oncology*Biology*Physics. 87(1). 67–72. 42 indexed citations

15.

Passoni, Paolo, Michele Reni, Giovanni Mauro Cattaneo, et al.. (2013). Hypofractionated Image-Guided IMRT in Advanced Pancreatic Cancer With Simultaneous Integrated Boost to Infiltrated Vessels Concomitant With Capecitabine: A Phase I Study. International Journal of Radiation Oncology*Biology*Physics. 87(5). 1000–1006. 23 indexed citations

16.

Cattaneo, Giovanni Mauro, Paolo Passoni, B. Longobardi, et al.. (2013). Dosimetric and clinical predictors of toxicity following combined chemotherapy and moderately hypofractionated rotational radiotherapy of locally advanced pancreatic adenocarcinoma. Radiotherapy and Oncology. 108(1). 66–71. 30 indexed citations

17.

Fiorino, C., Paolo Passoni, S. Broggi, et al.. (2012). Characterisation of rectal motion during neo-adjuvant radiochemotherapy for rectal cancer with image-guided tomotherapy: Implications for adaptive dose escalation strategies. Acta Oncologica. 51(3). 318–324. 21 indexed citations

18.

Reni, Michele, Stefano Cereda, Alessia Rognone, et al.. (2011). A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen). Cancer Chemotherapy and Pharmacology. 69(1). 115–123. 52 indexed citations

19.

Cattaneo, Giovanni Mauro, Paolo Passoni, N. Slim, et al.. (2010). Internal target volume defined by contrast-enhanced 4D-CT scan in unresectable pancreatic tumour: Evaluation and reproducibility. Radiotherapy and Oncology. 97(3). 525–529. 25 indexed citations

20.

Passoni, Paolo, Giovanni Mauro Cattaneo, S. Broggi, et al.. (2010). Planning design of locally advanced pancreatic carcinoma using 4DCT and IMRT/IGRT technologies. Acta Oncologica. 50(1). 72–80. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact